Mode
Text Size
Log in / Sign up
Phase 3 Completed N=37 Randomized Triple-blind Treatment

Bladder Scan of Residual Urine With New Catheter

Source: ClinicalTrials.gov NCT01048541 ↗
Enrolled (actual)
37
Serious AEs
0.0%
Results posted
Sep 2012
Primary outcomePrimary: Mean Residual Urine Volume — 12.4; 9.4 mL

Summary

Male intermittent catheters (ICs) range from 340-500 mm long, with the European standard minimum length being 360 mm for a catheter without a balloon and 275 mm for one with a balloon. This length is defined by hospital standards although it is known that the male urethra has an approximate maximum length of 29 cmA new intermittent catheter developed by Coloplast A/S is a 30-cm-long sterile, ready-to-use, hydrophilic-coated male catheter. There is a lack of clinical data documenting that male ICs that are shorter and more or less flexible than standard catheters can sufficiently empty the bladder of male subjects. This will be tested using ultrasound to measure residual urine in the bladder following catheterisation with new product and standard length catheter.

Outcome Measures

OutcomeResultp-value
PRIMARY
Mean Residual Urine Volume
12.4; 9.4
SECONDARY
The Difference in Incidence of Adverse Events (AEs) and Adverse Device Events (ADEs)
SECONDARY
Median Absolute RU Volume

Eligibility Criteria

Inclusion Criteria

  • Subject is a male IC user able to self-catheterise
  • Subject has used hydrophilic-coated ICs for at least 1 month
  • Subject is at least 18 years old.
  • Subject has provided informed consent.

Exclusion Criteria

  • Subject has symptoms of UTI (ie, fever, autonomic dysreflexia, spasticity, discomfort or pain over the kidney or bladder, onset/increase in incontinence episodes, cloudy urine with increased odour, malaise, lethargy, or sense of unease).
  • Subject has known abnormalities in the lower urinary tract.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01048541). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search